Skip to content

GENUFOOD ENERGY ENZYMES CORP.: 10-Q filed 2023-06-02

What GENUFOOD ENERGY ENZYMES CORP. reported in its quarterly report filed 2023-06-02 (fiscal Q2 2023): 32 published measures, 84 facts as tagged in accession 0001213900-23-045798.

This filing

Form
10-Q (quarterly report)
Filed
2023-06-02
Fiscal period
fiscal Q2 2023
Accession
0001213900-23-045798 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENUFOOD ENERGY ENZYMES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-03-31340,837USD
At 2022-09-30150,893USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-03-31205,180USD
At 2022-12-31-214,472USD
At 2022-09-30-83,349USD
At 2022-03-3186,159USD
At 2021-12-31149,377USD
At 2021-09-30253,472USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-03-31311,133USD
At 2022-09-30136,400USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-288,954USD90
2022-10-01 to 2023-03-31-438,742USD182
2022-10-01 to 2022-12-31-149,788USD92
2022-01-01 to 2022-03-31-63,224USD90
2021-10-01 to 2022-03-31-167,311USD182
2021-10-01 to 2021-12-31-104,087USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-10-01 to 2023-03-31-167,100USD182
2021-10-01 to 2022-03-31-116,306USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-10-01 to 2023-03-3120,167USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-10-01 to 2023-03-31362,000USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-10-01 to 2023-03-31-20,167USD182
2021-10-01 to 2022-03-31350,000USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-03-31-10,314,231USD
At 2022-09-30-9,875,489USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-01-01 to 2023-03-31473,950,309shares90
2022-10-01 to 2023-03-31385,390,227shares182
2022-01-01 to 2022-03-31299,686,921shares90
2021-10-01 to 2022-03-31299,686,921shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-01-01 to 2023-03-31473,950,309shares90
2022-10-01 to 2023-03-31385,390,227shares182
2022-01-01 to 2022-03-31299,686,921shares90
2021-10-01 to 2022-03-31299,686,921shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-03-3120,167USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-10-01 to 2023-03-3137,500USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-95,839USD90
2022-10-01 to 2023-03-31-244,834USD182
2022-01-01 to 2022-03-31-62,085USD90
2021-10-01 to 2022-03-31-165,425USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-03-31320,670USD
At 2022-09-30150,893USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-03-31104,931USD
At 2022-09-30205,016USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-01-01 to 2023-03-3195,839USD90
2022-10-01 to 2023-03-31244,834USD182
2022-01-01 to 2022-03-3162,085USD90
2021-10-01 to 2022-03-31165,425USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-03-31808,900,041shares
At 2022-09-30299,686,921shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-03-31311,133USD
At 2022-09-30136,400USD
At 2022-03-31242,965USD
At 2021-09-309,271USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-03-3116,952,092USD
At 2022-09-3016,927,592USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-09-30-193,558USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-03-3120,167USD
At 2022-09-300USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-03-3140USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-03-319,537USD
At 2022-09-3014,493USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-288,954USD90
2022-10-01 to 2023-03-31-438,742USD182
2022-01-01 to 2022-03-31-63,224USD90
2021-10-01 to 2022-03-31-167,311USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-95,311USD90
2022-10-01 to 2023-03-31-245,184USD182
2022-01-01 to 2022-03-31-63,218USD90
2021-10-01 to 2022-03-31-167,313USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-3195,839USD90
2022-10-01 to 2023-03-31244,834USD182
2022-01-01 to 2022-03-3162,085USD90
2021-10-01 to 2022-03-31165,425USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-750USD90
2022-10-01 to 2023-03-31-1,500USD182
2022-01-01 to 2022-03-31-1,145USD90
2021-10-01 to 2022-03-31-1,895USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-193,115USD90
2022-10-01 to 2023-03-31-193,908USD182
2022-01-01 to 2022-03-31-1,139USD90
2021-10-01 to 2022-03-31-1,886USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-10-01 to 2023-03-31362,000USD182

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-10-01 to 2023-03-31200USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-10-01 to 2023-03-31323USD182
2021-10-01 to 2022-03-31-3,307USD182

Inspect the source

Entity
GENUFOOD ENERGY ENZYMES CORP. / CIK 0001510518
Captured
SEC response SHA-256
62040db16ecdc4fe4fac3f00f0b1833b832cf2b3ca42726fa3827465e92e8aa0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001510518.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))